Aslani, Moriba -.

HRN: 21-60-62  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/26/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
06/26/2022
07/03/2022
IVT
135 Mg
8 Hrs
Amebiasis
Waiting Final Action 
06/30/2022
CEFTRIAXONE 1G (VIAL)
06/30/2022
07/07/2022
IV
810mg
Q24h
PCAP C
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: